PL442805A1 - Przylepiec medyczny o powolnym uwalnianiu - Google Patents

Przylepiec medyczny o powolnym uwalnianiu

Info

Publication number
PL442805A1
PL442805A1 PL442805A PL44280521A PL442805A1 PL 442805 A1 PL442805 A1 PL 442805A1 PL 442805 A PL442805 A PL 442805A PL 44280521 A PL44280521 A PL 44280521A PL 442805 A1 PL442805 A1 PL 442805A1
Authority
PL
Poland
Prior art keywords
slow release
medical adhesive
medical tape
tape based
release medical
Prior art date
Application number
PL442805A
Other languages
English (en)
Other versions
PL245596B1 (pl
Inventor
Carlo PIZZOCARO
Original Assignee
Fidia Farmaceutici S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici S.P.A filed Critical Fidia Farmaceutici S.P.A
Publication of PL442805A1 publication Critical patent/PL442805A1/pl
Publication of PL245596B1 publication Critical patent/PL245596B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

Opisano przylepiec medyczny o powolnym uwalnianiu na bazie diklofenaku, a w szczególności przylepiec medyczny na bazie soli sodowej diklofenaku, którego skład umożliwia ciągłe uwalnianie substancji czynnej miejscowo w terapeutycznie czynnych stężeniach w sposób ciągły przez 24 godziny, a także polimerową matrycę klejową (PSA) do stosowania w przylepcu medycznym na bazie soli sodowej diklofenaku.
PL442805A 2020-05-20 2021-05-18 Przylepiec medyczny i jego zastosowanie oraz matryca kleju przylepcowego PL245596B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102020000011686A IT202000011686A1 (it) 2020-05-20 2020-05-20 Cerotto medicato a lento rilascio
IT102020000011686 2020-05-20
PCT/IB2021/054261 WO2021234562A1 (en) 2020-05-20 2021-05-18 Slow-release medical plaster

Publications (2)

Publication Number Publication Date
PL442805A1 true PL442805A1 (pl) 2023-07-03
PL245596B1 PL245596B1 (pl) 2024-09-02

Family

ID=71994907

Family Applications (2)

Application Number Title Priority Date Filing Date
PL21726205.4T PL4153151T3 (pl) 2020-05-20 2021-05-18 Przylepiec medyczny o powolnym uwalnianiu
PL442805A PL245596B1 (pl) 2020-05-20 2021-05-18 Przylepiec medyczny i jego zastosowanie oraz matryca kleju przylepcowego

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL21726205.4T PL4153151T3 (pl) 2020-05-20 2021-05-18 Przylepiec medyczny o powolnym uwalnianiu

Country Status (36)

Country Link
US (1) US20230190668A1 (pl)
EP (1) EP4153151B1 (pl)
KR (1) KR20230013033A (pl)
CN (1) CN115666537B (pl)
AR (1) AR122136A1 (pl)
AT (1) AT525409A3 (pl)
BE (1) BE1028251B1 (pl)
CA (1) CA3178964A1 (pl)
CH (1) CH718822B1 (pl)
CZ (1) CZ2022461A3 (pl)
DE (1) DE112021002871T5 (pl)
DK (2) DK4153151T3 (pl)
EE (1) EE05862B1 (pl)
ES (2) ES2936185B2 (pl)
FI (1) FI4153151T3 (pl)
FR (1) FR3110397B1 (pl)
GB (1) GB2610106B (pl)
GR (1) GR1010304B (pl)
HR (1) HRP20240192T1 (pl)
HU (2) HU231555B1 (pl)
IE (1) IE20210109A1 (pl)
IT (1) IT202000011686A1 (pl)
LT (1) LT4153151T (pl)
LU (1) LU501245B1 (pl)
MA (1) MA59594B1 (pl)
MD (1) MD4153151T2 (pl)
NL (1) NL2028233B1 (pl)
PL (2) PL4153151T3 (pl)
PT (2) PT4153151T (pl)
RO (1) RO137440A2 (pl)
RS (1) RS65194B1 (pl)
SI (1) SI4153151T1 (pl)
SK (1) SK289303B6 (pl)
SM (1) SMT202400017T1 (pl)
TR (1) TR2021008324A2 (pl)
WO (1) WO2021234562A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950408A1 (en) * 1997-07-18 1999-10-20 Teikoku Seiyaku Co., Ltd. Oily patches for external use containing diclofenac sodium
CN1489996A (zh) * 2003-06-25 2004-04-21 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
WO2012089256A1 (en) * 2010-12-29 2012-07-05 Pharmafilm S.R.L. Medicated patch for improved transdermal permeation of diclofenac diethylammonium
US20150202171A1 (en) * 2012-06-20 2015-07-23 Hisamitsu Pharaceutical Co., Inc. Patch

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208463A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 経皮吸収性に優れた消炎鎮痛組成物
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
ATE529094T1 (de) * 2003-01-27 2011-11-15 Vitamin C60 Biores Corp Zusammensetzung zur äusseren anwendung
EP1807033B1 (en) * 2004-10-08 2016-07-20 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
PT1877509E (pt) 2005-03-17 2012-01-24 Pharmafilm S R L Sistema aquoso polimérico para a preparação de matriz de adesivo sensível à pressão
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
EP2714019A1 (en) * 2011-05-26 2014-04-09 Novartis AG Compositions for percutaneous administration of physiologically active agents
US9962349B2 (en) 2014-10-17 2018-05-08 Fidia Farmaceutici S.P.A. Dermal therapeutic system with high adhesivity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950408A1 (en) * 1997-07-18 1999-10-20 Teikoku Seiyaku Co., Ltd. Oily patches for external use containing diclofenac sodium
CN1489996A (zh) * 2003-06-25 2004-04-21 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
WO2012089256A1 (en) * 2010-12-29 2012-07-05 Pharmafilm S.R.L. Medicated patch for improved transdermal permeation of diclofenac diethylammonium
US20150202171A1 (en) * 2012-06-20 2015-07-23 Hisamitsu Pharaceutical Co., Inc. Patch

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MDPI; https://www.mdpi.com/1999-4923/4/3/413; FINI ADAMO ET AL, Diclofenac Salts, VIII. Effect of the Counterions on the Permeation through Porcine Membrane from Aqueous Saturated Solutions, Pharmaceutics 2012, 4(3), 413-429 *

Also Published As

Publication number Publication date
KR20230013033A (ko) 2023-01-26
EE202200014A (et) 2022-12-15
AT525409A2 (de) 2023-03-15
SK500562022A3 (sk) 2022-12-21
DE112021002871T5 (de) 2023-03-23
BE1028251B1 (fr) 2022-04-05
SMT202400017T1 (it) 2024-03-13
CN115666537A (zh) 2023-01-31
EP4153151B1 (en) 2023-11-22
LT4153151T (lt) 2024-02-26
NL2028233A (en) 2021-12-01
MA59594B1 (fr) 2024-03-29
NL2028233B1 (en) 2023-10-25
FR3110397B1 (fr) 2025-05-16
AT525409A3 (de) 2023-04-15
CH718822B1 (it) 2024-01-15
ES2936185B2 (es) 2025-06-12
LU501245A1 (fr) 2022-02-15
SK289303B6 (sk) 2025-03-26
RS65194B1 (sr) 2024-03-29
EE05862B1 (et) 2024-01-15
FR3110397A1 (fr) 2021-11-26
GB2610106B (en) 2024-08-07
HRP20240192T1 (hr) 2024-05-10
ES2972189T3 (es) 2024-06-11
GB2610106A (en) 2023-02-22
RO137440A2 (ro) 2023-05-30
CA3178964A1 (en) 2021-11-25
MD4153151T2 (ro) 2024-04-30
PL245596B1 (pl) 2024-09-02
FI4153151T3 (fi) 2024-02-08
LU501245B1 (fr) 2022-05-17
CN115666537B (zh) 2025-10-17
HU231555B1 (hu) 2024-11-28
PT4153151T (pt) 2024-02-05
ES2936185R1 (es) 2023-10-11
SI4153151T1 (sl) 2024-03-29
IT202000011686A1 (it) 2021-11-20
GB202217015D0 (en) 2022-12-28
EP4153151A1 (en) 2023-03-29
AR122136A1 (es) 2022-08-17
TR2021008324A2 (tr) 2021-12-21
GR1010304B (el) 2022-09-28
HUE066041T2 (hu) 2024-07-28
PL4153151T3 (pl) 2024-04-22
BE1028251A1 (fr) 2021-11-29
WO2021234562A1 (en) 2021-11-25
IE20210109A1 (en) 2022-08-17
DK181719B1 (en) 2024-11-06
CZ2022461A3 (cs) 2022-12-14
ES2936185A2 (es) 2023-03-14
DK202201037A1 (en) 2022-11-21
PT2021234562B (pt) 2025-12-26
DK4153151T3 (da) 2024-02-05
HUP2200459A2 (hu) 2023-03-28
US20230190668A1 (en) 2023-06-22
GR20210100319A (el) 2021-12-09

Similar Documents

Publication Publication Date Title
ATE421892T1 (de) Wundverbände für die kontrollierte freisetzung von therapeutischen mitteln
UY39129A (es) Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead
DK1635808T3 (da) Topisk anvendelse af valproinsyre til forebyggelse eller behandling af psoriasis og acne
MX9205389A (es) Composicion farmaceutica que contiene felbinac.
BR9803300A (pt) Formulação farmacêutica.
DE602007008385D1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
ES2099974T3 (es) Tratamiento de la piel con propiedades de mejora de la adherencia.
BR112022016425A2 (pt) Curativo hemostático, e, método para fabricar o mesmo
BR112024001927A2 (pt) Formas de dosagem gastrorretentivas de 5-hidroxitriptofano
CY1111905T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα εναν επιλεκτικο αναστολεα της αμινοπεπτιδασης α, ειδικα τον ec33, για τη μειωση της αρτηριακης πιεσεως
PL442805A1 (pl) Przylepiec medyczny o powolnym uwalnianiu
MX2024010920A (es) Activadores de las celulas t efectoras
ITPD20050207A1 (it) Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
NO20031211L (no) Plaster omfattende diclofenac
ES451188A1 (es) Un procedimiento para la preparacion de nuevas poliaminas.
AR039977A1 (es) Composicion a base de diclofenac para el tratamiento topico de afecciones de la cavidad orofaringea
UY23355A1 (es) Formulacion para verter destinada a la aplicacion de antihelminticos
AR011061A1 (es) Compuestos inhibidores de cetona t-terminal de metaloproteinasas de matriz y de la secrecion fent alfa, uso del mismo para la manufactura de un medicamenty una composicion que los contiene
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
CO5011042A1 (es) Uso de una oxazolidinona para la fabricacion de un medicamento para administracion topica
BR112022025467A2 (pt) Tratamento para infecção por coronavírus humano
BR0108041A (pt) Nova forma galênica oral de liberação prolongada da molsidomina
PE20061050A1 (es) Composicion farmaceutica de liberacion lenta de (+)-(2s,3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol
PE20251703A1 (es) Composicion farmaceutica de liberacion controlada
BR0307039A (pt) Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias